Aminopromazine

Aminopromazine

SCHEMBL25156

CN(C)CC(CN1c2ccccc2Sc2ccccc21)N(C)C

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 6/20 0.70
HTR1A P08908 6/20 0.70
CHRM1 P11229 6/20 0.70
ADRA1A P35348 6/20 0.70
OPRM1 P35372 6/20 0.70
DRD3 P35462 6/20 0.70
KCNH2 Q12809 6/20 0.70
ADRA2A P08913 5/20 0.70
DRD1 P21728 5/20 0.70
SLC6A2 P23975 4/20 0.70
SLC6A4 P31645 4/20 0.70
TBXA2R P21731 2/20 0.70
HRH3 Q9Y5N1 2/20 0.70
ABCB11 O95342 1/20 0.70
SLC6A3 Q01959 1/20 0.70
CYP2D6 P10635 7/20 0.65
LMNA P02545 4/20 0.65
PTGS1 P23219 4/20 0.65
CYP1A2 P05177 4/20 0.65
ALDH1A1 P00352 4/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminopromazine SCHEMBL30990818 1.00 CHRM2 (0.70) CHRM2HTR1ACHRM1ADRA1AOPRM1
Aminopromazine SCHEMBL5307944 0.98 CHRM2 (0.68) CHRM2HTR1ACHRM1ADRA1AOPRM1
Aminopromazine SCHEMBL11041925 0.88 GFER (0.59) CHRM2HTR1ACHRM1ADRA1AOPRM1
Aminopromazine SCHEMBL11041921 0.88 GFER (0.59) CHRM2HTR1ACHRM1ADRA1AOPRM1
SCHEMBL3475700 0.84 CYP2D6 (0.65) CHRM2HTR1ACHRM1ADRA1AOPRM1
Hydrochloric Acid SCHEMBL8050972 0.83 LMNA (0.66) CHRM2HTR1ACHRM1ADRA1AOPRM1
Methylpromazine SCHEMBL29354434 0.83 CHRM2 (1.00) CHRM2HTR1ACHRM1ADRA1AOPRM1
Methylpromazine SCHEMBL18994 0.83 CHRM2 (1.00) CHRM2HTR1ACHRM1ADRA1AOPRM1
Methylpromazine SCHEMBL18993 0.83 CHRM2 (1.00) CHRM2HTR1ACHRM1ADRA1AOPRM1
Bromide SCHEMBL22588344 0.82 CYP2D6 (0.66) CHRM2HTR1ACHRM1ADRA1AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 639 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11534375-B2 Solvent-free method of encapsulating a hydrophobic active AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2022-12-27 US claimed
US-10815313-B2 Method for preparing a cellulose sponge SHANXI PISHON BIOMEDICAL TECHNOLOGY CO., LTD (CN) 2020-10-27 US claimed
US-20200179248-A1 SOLVENT-FREE METHOD OF ENCAPSULATING A HYDROPHOBIC ACTIVE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-06-11 US claimed
WO-2018182509-A1 SOLVENT-FREE METHOD OF ENCAPSULATING A HYDROPHOBIC ACTIVE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-10-04 WO claimed
CN-108144109-A A kind of aerogel dressing of the interpenetrating networks cross-linked structure containing honey 浙江海创医疗器械有限公司 2018-06-12 CN claimed
US-20180148515-A1 METHOD FOR PREPARING A CELLULOSE SPONGE PISHON BIOMEDICAL CO., LTD (TW) 2018-05-31 US claimed
CN-108018133-A Without aviation kerosine can rapid cleaning mahjong asepsis environment-protecting antibacterial cleaning agent 刘海报 2018-05-11 CN claimed
CN-107840601-A A kind of nano-particles reinforcement type antibacterial and mouldproof diatom ooze 上海蕴彩实业有限公司 2018-03-27 CN claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
EP-2007394-B1 NOVEL USE OF ANTIHISTAMINE AGENTS FOR THE PREVENTIVE OR EARLY TREATMENT OF INFLAMMATORY SYNDROMES, IN PARTICULAR THOSE TRIGGERED BY TOGAVIRUSES PF MEDICAMENT (FR) 2012-10-10 EP claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
WO-2006102029-A9 METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE DOV PHARMACEUTICAL INC (US) 2006-12-07 WO claimed
WO-2006102029-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE DOV PHARMACEUTICAL, INC. (US) 2006-09-28 WO claimed
EP-0687172-B1 SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF PHARMACIA AB (SE) 2002-12-04 EP claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
US-6207178-B1 STABLE SUSPENSION KABI PHARMACIA AB (SE) 2001-03-27 US claimed
EP-1005651-A1 METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS SUPRATEK PHARMA, INC. (CA) 2000-06-07 EP claimed
WO-1999008112-A1 METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS SUPRATEK PHARMA INC. (CA) 1999-02-18 WO claimed
US-5785976-A Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof PHARMACIA & UPJOHN AB (SE) 1998-07-28 US claimed
US-5552501-A CO ADDITION POLYMERIZATION WITH DIACETONE ACRYLAMIDE WITH FREE RADICAL CATALYSTS PATEL KAMALA D (US) 1996-09-03 US claimed